Candida albicans, the most common fungal pathogen of humans, possesses an oestrogen (estrogen)-binding protein (EBP) that binds oestrogens with high affinity and specificity. The gene that encodes the EBP (CaEBP1) has been cloned and sequenced and shown to be structurally related to the old yellow enzyme from Saccharornyces cerevisiae. Here, we report the purification and the subcellular localization of the EBP from C. albicans. Using ion-exchange chromatography and an oestradiol affinity column, the EBP was purified from a strain of C. albicans (strain 422) which was selected because it constitutively expressed elevated levels of the binding protein. The purified protein displayed a subunit molecular mass of approximately 46 kDa when examined by denaturing gel electrophoresis, which is consistent with the size estimated from the sequence of the cloned CaEBPl gene. An immunoaffinity column, prepared using a polyclonal antisera generated against EBP, depleted the oestrogen-binding activity from C. albicans cell extracts. Western blot analysis showed that the antisera specifically recognized the EBP from C. albicans. The antibodies also recognized the protein when the cloned CaEBPl gene was expressed in 5. cerevisiae and did not cross react with 5. cerevisiae proteins. Using electron microscopy and antigen detection by immunogold staining, the EBP appeared to be primarily associated with vacuoles. However, when overexpressed in 5. cerevisiae, the EBP was found diffusely throughout the cell. In conclusion, the EBP has been purified from C. albicans and antibodies generated against the protein were used to demonstrate that EBP is found associated with vacuoles in C. albicans.
INTRODUCTION
Candida albicans, a dimorphic yeast, is one of the most important human fungal pathogens worldwide, notably causing serious infections in immunocompromised patients (Crislip & Edwards, 1989 ; Diamond, 1991 ; Saral, 1991 ; Anaissie, 1992) . Previous studies from our laboratory have identified an oestrogen (estrogen)-binding protein (EBP) in C. albicans which exhibits high binding affinity for oestradiol and related mammalian steroids (Skowronski & Feldman, 1989) . Since epidemiological evidence indicates that oestrogens increase susceptibility to Candida infections (Mitchell, 1988 Witkin, 1989) and oestradiol has been shown to stimulate yeast form to mycelial transition (Kinsman et al., 1988) , understanding the role of the EBP as a potential regulatory molecule in these oestrogenic actions is imperative. We have recently cloned and sequenced the C.
albicans EBP gene (CaEBPI) and have shown that the protein encoded by this gene contains a highly conserved amino acid sequence that is found in several flavincontaining enzymes (Madani e t al., 1994) . In addition, EBP displays a 45 % amino acid identity to the old yellow enzyme (OYE), an oxidoreductase present in Saccharomyes cerevisiae and other yeast (Saito e t al., 1991; Stott e t al., 1993) . Based on these findings, we showed that in addition to having oestrogen-binding properties, the EBP also had oxidoreductase activity (Madani e t al., 1994) . Furthermore, we showed that the EBP oxidoreductase activity could be inhibited by oestrogens and further investigation of the enzymic properties of the protein are currently ongoing. In this report, we describe the strategy we used t o purify the C. albicans EBP, the development of antibodies against EBP, and the immunolocalization of the protein by electron microscopy. O u r findings indicate that EBP is mainly localized near the inner surface of the tonoplast membrane of the vacuole in C. albicans.
Materials. Affigel 102, Affigel blue, Econo-Pac Serum IgG purification kit, ammonium persulfate and p-mercaptoethanol were purchased from Bio-Rad Laboratories. The PharmaLink Immobilization kit was from Pierce. PD-10 columns and DEAE-Sephacel were purchased from Pharmacia Fine Chemicals. Hydrazide AvidGel Ax was obtained from BioProbe International. Sabouraud-dextrose medium was from Difco Laboratories. Freund's adjuvant and 17P-oestradiol hemisuccinate were from Sigma. Corticosterone hemisuccinate was from Steraloids. Goat anti-rabbit antibody conjugated to 1.4 nm gold particles was obtained from Nanoprobes. ECL Western blot system and Hyperfilm-MP were purchased from Amersham. Zymolase-60000 was from Seikagaku Kogyo. Tris base, acrylamide, N',N'-methylene-bis-acrylamide and SDS were from United States Biochemical.
Ligand-binding assay. Ligand-binding assays done in 0.5 ml volumes containing approximately 1 mg protein (ml sample)-' were incubated with 25 nM [3H]17B-oestradiol for 1 h at 4 "C with or without a 250-fold excess of unlabelled hormone. The unbound hormone was removed by incubation with an equal volume of a suspension of 1 % (w/v) charcoal coated with 0.1 YO dextran-T70 followed by centrifugation at 4000 g for 10 rnin at 4 "C (Skowronski & Feldman, 1989) . Bound [3H]17P-oestradiol was determined by liquid scintillation counting. Specific binding was calculated by subtracting non-specific binding (determined in the presence of 250-fold excess of unlabelled 17B-oestradiol) from the total binding (determined in the absence of unlabelled 17P-oestradiol).
Protein determination. The protein concentration was determined by the Bradford method (Bradford, 1976) .
Preparation of 17p-oestradiol agarose. The PharmaLink Immobilization kit was used to immobilize 17/3-oestradiol to agarose as described by the manufacturer. Briefly, 2 ml of a 10 mM solution of l7g-oestradiol dissolved in 100 YO ethanol was mixed dropwise with an equal volume of coupling buffer. This mixture was added to the gel, which had been preequilibrated with 5 ml of a 50% coupling buffer/50% ethanol solution. Coupling was initiated by the addition of 0.1 ml 4 M formaldehyde. The gel-ligand suspension was incubated at 38 "C for 24 h with gentle shaking. After coupling, the gel was transferred into a column and washed with 30 ml PharmaLink wash buffer to remove the uncoupled ligand and formaldehyde. The column was then equilibrated with T E D (10 mM Tris, pH 7.0, 1 mM EDTA, 1 mM DTT) buffer and stored at 4 "C.
SDSPAGE. Protein samples diluted in SDS-sample buffer (62.5 mM Tris, pH 6-8, l o % , v/v, glycerol, 2 %, w/v, SDS, 5 YO, w/v, /3-mercaptoethanol and 0.00125 % bromophenol blue) were heated at 100 "C for 4 min and electrophoresed at 120 V at ambient temperature in 10 YO (w/v) polyacrylamide gels (acrylamide : bis-acrylamide ; 37.5 : 1) containing 1 YO (w/v) SDS according to the method of Laemmli (1970) . After electrophoresis, the gels were stained with 0.25 % Coomassie Brilliant Blue R250 in 30% (v/v) methanol/7% (v/v) acetic acid and destained in 30 YO methanol/7 YO acetic acid.
Purification of EBP
Cell strain and growth conditions. For purification of EBP, C. albicans strain 422 was grown in 2 1 Sabouraud-dextrose broth in volumes of 500 ml per 1 1 round bottom flask. Cultures were started from cells grown overnight on the same medium and were incubated at 37 OC with shaking at 240 r.p.m. When the cultures had reached stationary growth phase (OD, , , Z 20) , approximately 16 h post inoculation, the cells were harvested by centrifugation at 3000g for 10 min at 4 "C.
Preparation of crude cell homogenate. Cell pellets were washed once with T E D buffer and then resuspended in an equal volume (v/v) of T E D buffer containing a protease inhibitor cocktail composed of a working concentration of 0.5 pg leupeptin ml-', 1.4 pg pepstatin ml-', 2 pg chymostatin ml-', 0.33 mg benzamidine ml-' and 50 pg soybean trypsin inhibitor ml-'. Using a Biospec bead beater equipped with an ice-jacket, the cells were broken by agitation with glass beads (0.5 mm) employing eight 30 s bursts, each followed by 1 min of cooling. The crude cell homogenate was centrifuged at 3000 g for 5 min at 4°C to remove unbroken cells and glass beads. The supernatant was centrifuged at 210000g for 30 min at 4 "C to obtain the cytosolic fraction.
DEAE-ion-exchange chromatography. The crude cytosolic fraction was titrated to pH 7.0 with NaOH and pumped at a flow rate of 25 ml h-' onto a 20 x 5 cm column containing DEAE-Sephacel equilibrated with TED buffer. The column was washed with one column volume of TED buffer to remove non-binding proteins. The flow-through fraction, which contained EBP, was collected and saved as the 'DEAE column eluate'. The DEAE column eluate was concentrated by ultrafiltration using an Amicon stirred cell apparatus equipped with a YM-30 membrane and then stored at 4 "C.
Oestradiol affinity chromatography. The concentrated DEAE column eluate was then applied to a 1 x 1 cm column containing 17B-oestradiol agarose and incubated with the resin at ambient temperature for 1 h. After incubation, the column was washed with 20 ml TED buffer to remove unbound proteins. EBP was eluted from the resin by applying a 20 ml solution of 40 pM 178-oestradiol in TED buffer. Protein eluted from the column was monitored for A,,,. Fractions containing protein were pooled and concentrated by ultrafiltration using a micro-concentrator equipped with a YM-30 membrane and then stored at -20 "C.
Generation of polyclonal antisera. Two New Zealand White rabbits were bled prior to the initial injection to obtain preimmune serum. Purified EBP (1 ml; 150 pg ml-') which had been mixed with an equal volume of Freund's complete adjuvant was then injected intradermally at six different sites into the rabbits. Three weeks after the initial immunization, the rabbits received booster injections with EBP (100 pg ml-l) mixed in Freund's incomplete adjuvant. Booster shots were then given at 2 week intervals over a 6 week period. The rabbits were bled by cardiac puncture. Whole blood was allowed to clot at ambient temperature and then centrifuged at 2000 g to obtain the crude antiserum. The IgG fraction was purified from the rabbit sera using an Econo-Pac IgG purification kit as described by the manufacturer.
Preparation of immunoaff inity column. The IgG fraction was incubated with 10 mM NaIO, at ambient temperature for 1 h to oxidize the IgG. Unreacted NaIO, was removed using a PD-10 column and the oxidized IgG was mixed with 1.2 ml Hydrazide AvidGel Ax and incubated at 4 "C overnight with gentle shaking. The IgG-coupled gel was packed into a column and washed with 5 ml H,O followed by 5 ml 1 M NaC1, and then extensively with K T E D buffer and stored at 4 "C.
Oestrogen-binding protein in Candida albicans lmmunoaffinity chromatography. Cytosolic fractions from C. albicans 422 or S. cerevisiae transformed with the CaEBPl gene were applied to immunoaffinity columns containing pre-immune IgG or anti-EBP IgG. Samples were passed through the column three times to obtain the immunodepleted fraction. The columns were then washed with 10 ml KTED buffer to remove non-binding proteins. Proteins adsorbed to the immunoaffinity resin were eluted by washing with 4 M MgCl,, 4 mM DTT. The fractions from each step were assayed for [3H] l7b-oestradiol binding and by Western blotting.
Western blotting. Proteins electrophoresed on SDS-PAGE were transferred at 0.4 A onto 0.2 pm nitrocellulose filters in Tris-glycine-SDS buffer containing 20 % (v/v) methanol. The filters were washed with TBS buffer (0.1 M Tris, pH 7.2, 0-4 M NaC1) and incubated with 5 % (v/v) Carnation nonfat milk in TBS at ambient temperature for 20 min. The blots were incubated at 4 "C overnight with pre-immune or immune sera. The blots were washed with TBS containing 1 % (v/v) Tween 20, blocked with nonfat milk, and then incubated with a goat anti-rabbit antibody conjugated to horseradish peroxidase for 2 h at ambient temperature. The blots were washed with TBS containing 1 YO Tween 20 and then processed as described by the manufacturer using the ECL Western blot system. The chemiluminescent signal was detected by exposing the blot to Hyperfilm-MP and then developing the film using an automatic film processor. lmmunoelectron microscopy. Cell samples for electron microscopy were washed with PBS (0.145 M NaC1, 0.15 M sodium phosphate) and resuspended in PBS containing 0.2% bmercaptoethanol. Cell walls were removed by digestion with zymolase-60000 (0.25 mg ml-l) and incubation at 37 O C for 30min. The remainder of the procedure was performed at ambient temperature. The spheroplasts were rinsed gently with PBS and then fixed with 1 % (w/v) glutaraldehyde for 15 min. The cell suspension was neutralized with 0.02 M glycine in PBS for 5 min and then incubated with pre-immune serum or anti-EBP antisera for 30 min with occasional shaking. The cells were washed with PBS containing 0.5% BSA and incubated with goat anti-rabbit antibody conjugated with 1.4 nm gold for 30 min. To immobilize the gold-conjugated antibodies with the antigen, 1 YO glutaraldehyde was applied as a post-fixative. The neutral pH silver development procedure was performed to enhance the visibility of the gold particles as described by the manufacturer (Nanoprobes). Osmium fixation, Spurr embedding and thin sectioning were performed according to standard procedures. The thin sections were examined by electron microscopy using a Philips 301 transmission electron microscope.
RESULTS

EBP levels during Candida growth
In order t o purify the EBP from C. albicans we first sought t o ascertain the conditions that would maximize the amount of EBP in the starting material. In previous studies using C. albicans strain 158 grown in Sabourauddextrose medium, we observed that the organism expressed elevated levels of EBP early in the growth phase which then decreased rapidly and substantially as the cell density increased and the cells entered the stationary growth phase (Skowronski & Feldman, 1989) .
However, we observed that the EBP levels in the stationary growth phase were quite variable among the different strains of C. albicans that we examined and one strain in particular, C. albicans strain 422, displayed a 17-fold higher abundance of EBP as compared to strain 158 (Skowronski & Feldman, 1989) . For this reason, we compared the EBP levels in these two strains during growth on Sabouraud-dextrose medium. As shown in Fig. 1 (Fig. 1) . Since EBP appears to be expressed constitutively and at substantially elevated levels in C. albicans 422, this strain was chosen as the source of EBP for the protein purification.
EBP purification
The constitutive expression of high levels of EBP in C. and subjected to gel electrophoresis. After transfer to nitrocellulose filters, the blots were incubated with anti-EBP antisera. Lanes: 1, C. albicans 422 cytosol; 2, DEAE flowthrough fraction; 3, EBP purified from C. albicans strain 422 following affinity chromatography; 4, EBP purified from C. albicans strain 158.
then passed over an oestradiol affinity column. The EBP that was bound to the oestradiol resin was then eluted using a high concentration (40 pM) of oestradiol. The SDS-polyacrylamide gel of the sequential steps used in the purification scheme is shown in Fig. 2 . Multiple bands are detected by Coomassie Brilliant Blue staining in the cytosol and DEAE flow-through fractions ; however, only a single band with molecular mass of approximately 46 kDa is present in the sample eluted from the oestradiol affinity column (Fig. 2, lane 4) . These results demonstrate that the oestradiol affinity column specifically binds EBP, which can then be isolated as a pure protein.
Generation of polyclonal antibodies
The purified EBP was used to immunize rabbits in order to generate polyclonal antibodies. The IgG fraction was then purified and used to probe a Western blot of samples taken during the EBP purification. As shown in Fig. 3 , the antiserum detected a single band with a molecular mass of 46 kDa in the cytosol and the DEAE flow-through fractions (Fig. 3 , lanes 1 and 2) and in the purified EBP sample (Fig. 3, lane 3) . The antiserum also recognized EBP in the cytosolic fraction of C. albicans 158 (Fig. 3 , lane 4).
lmmunodepletion
In order to confirm that the antiserum recognized native EBP, we used an immunodepletion strategy employing an anti-EBP antibody column to deplete EBP from cell extracts. Cytosol from C. albicans 422 was applied to an anti-EBP antibody column, or as a control, to a preimmune IgG column. The flow-through fractions were monitored for EBP by immunoblotting. After passage through the anti-EBP antibody column, the bound EBP was then eluted using 4 M MgCl,. Western blot analysis confirmed that the EBP was present in the 4 M MgC1, fraction and had been depleted from the flowthrough fraction (Fig. 4a, lanes 3 and 4) . In contrast, when cytosol was passed onto the pre-immune IgG column, the EBP was not depleted from the starting material. Western blot analysis confirmed that the EBP was present in the flow-through fraction and not in the 4 M MgC1, fraction (Fig. 4b, lanes 3 and 4) .
Antibody detection of EBP overexpressed in S. cerewisiae
In addition to detecting the native EBP in C. albicans, we addressed the question of whether the antibody would recognize the protein encoded by the cloned C. albicans EBP gene. In these experiments, the C. albicans EBP gene was overexpressed in S. cerevisiae (Madani e t al., 1994) and cytosolic fractions were passed through the anti-EBP antibody column. Western blot analysis showed no evidence of cross-reacting material in the control cytosol of S. cerevisiae transfected with the expression vector without the C. albicans EBP gene (Fig. 5, lane 1) ; however, the antiserum clearly recognized the native EBP ( (Fig. 5, lanes 6 and 7) . Bands of lesser intensity were observed in the flow-through as well as the wash fractions (Fig. 5, lanes 4 and 5) since not all of the EBP was bound to the column.
Subcellular localization of EBP
The anti-EBP antibodies were used to localize EBP in C. albicans strains 422 and 158 by immunoelectron microscopy using immunogold staining. As shown in Fig. 6(a) , most of the immunogold particles were associated with the vacuoles and a few particles were dispersed within the cytoplasm. At higher magnification, the immunogold particles appeared to be distributed near the inner surface of the tonoplast membrane. In control samples reacted with pre-immune serum, no gold particles were observed (Fig. 6b) . The anti-EBP antibodies were also used to localize EBP in S. cerevisiae overexpressing the C. albicans EBP7 gene (Madani e t al., 1994) . As shown in Fig. 7(a) , the immunogold particles were not localized to the vacuole but were widely distributed throughout the cytoplasm as well as the nucleus. Cells incubated with preimmune serum exhibited no immunogold particles (Fig.  7b) .
DISCUSSION
The goals of this study were to purify the C. albicans EBP and to generate polyclonal antibodies which could then be used to determine the subcellular localization of the protein. Our first objective was to optimize the amount of EBP in the starting material for the purification. From our previous studies, we observed that the amount of oestrogen binding present in cell extracts varied between strains of C. albicans. In C. albicans strain 158, the level of oestrogen binding was tightly regulated and dependent upon the media in which the cells were grown (Skowronski & Feldman, 1989; and Fig. 1) . When grown in Sabouraud-dextrose medium, the amount of oestrogen binding detected in C. albicans strain 158 was highest in the early phase of growth and then declined rapidly as the cells entered the stationary growth phase. In contrast, when C. albicans strain 422 was grown under identical conditions, the amount of oestrogen binding was constantly high at all of the phases of the growth curve. Thus, in order to isolate pure EBP we took advantage of this constitutive and elevated production of the protein and used C. albicans strain 422 as the source of the starting material for the protein purification.
We purified EBP from cell extracts using a combination of DEAE-ion-exchange and oestradiol affinity chromatography. Interestingly, during the DEAE-ion-exchange step in which the EBP eluted in the application flowthrough and column washing fractions, the amount of measurable EBP was nearly double the amount that was detected in the starting crude cell extract. A likely explanation for this observation is that an endogenous ligand or inhibitor of [3H] 17B-oestradiol binding was removed by this chromatography process. The key step in isolating pure EBP was use of the oestradiol agarose affinity chromatography column. This step provided the means to isolate the protein to homogeneity as demonstrated by the presence of a single protein band on denaturing gels.
We then used the purified EBP to generate a polyclonal antiserum in rabbits. The specificity of the antibody preparation was confirmed by Western blotting, which showed that the antiserum recognized the purified EBP and only a single 46 kDa protein band in C. albicans strains 158 and 422 cell extracts. Further proof that the antiserum recognized the oestrogen binder in C. albicans was demonstrated by the experiment which showed that the oestrogen-binding activity in cell extracts could be immunodepleted by passing the extract through an immunoaffinity column prepared with the polyclonal antiserum. The subsequent elution of the EBP from the antibody column was confirmed by Western blotting.
The anti-EBP antiserum was used to determine the subcellular localization of EBP in C. albicans. Using 1.4 nm gold particles conjugated to anti-EBP antibodies, electron micrographs showed that the EBP was found mainly distributed to the vacuole. The immunoreactive gold particles appeared to be associated with the internal tonoplast, although the EBP might be soluble within the vacuole. The immunocytochemical data also reflected the differences in the EBP levels that we observed between the two C. albicans strains 158 and 422.
The anti-EBP antiserum also recognized the protein expressed from the cloned CaEBP gene. Interestingly, when the gene was expressed in 5'. cerevisiae and examined by immunoelectron cytochemistry, the gold particles appeared to be distributed throughout the cell with no apparent association to a subcellular locus.
The fungal vacuole is analogous to the mammalian lysosome and subserves many functions. Prominent among these are macromolecular degradation and proteolysis, maintenance of cytosolic ion and pH homeostasis and metabolite storage (Klionsky etal., 1990) . The vacuole contains a number of enzymes including peptidases, hydrolases, phosphatases and ATPases which carry out many of these processes. From the cloning of the C. albicans EBP gene, we ascertained that EBP is related to a family of bacterial flavoproteins and to the OYE from Saccbaromyces species. The OYE is an oxidoreductase and we have shown that EBP also possesses this enzymic activity. The subcellular localization of the OYE has not yet been reported, thus EBP represents the first member of this family of enzymes to be identified as vacuolar.
In recent years, extensive investigation has been carried out, primarily in S. cerevisiae, into the mechanisms involved in targeting enzymes for transport to the vacuole and activating the enzyme after localization within the organelle (Klionsky e t al., 1990) . Many of these proteins have a signal peptide that is required for organelle targeting and a few have a pro-peptide sequence which, on arrival at the vacuole, is cleaved to generate the mature enzyme. Within the endoplasmic reticulum and the Golgi apparatus, en rotlte to the vacuole, many of these vacuolar proteins frequently undergo N-linked glycosylation. EBP may also be glycosylated since the amino acid sequence Asn-Xaa-Thr identified as a conserved sequence for Nlinked glycosylation is present in EBP at amino acid residues 331-333. Structural analysis of the EBP did not reveal a hydrophobic signal sequence nor an apparent membrane-spanning domain within the protein.
Although EBP does not appear to contain the elements required for signal sequence recognition to cross a membrane, some vacuolar enzymes, particularly amannosidase, have been demonstrated to enter the vacuole by translocation across the vacuolar membrane from the cytoplasm without requiring a signal peptide (Yoshihisa & Anraku, 1989 ). An interesting question is raised by the S. cerevisiae overexpression system, where EBP fails to localize within the vacuole. Although the S.
cerevisiae strain that was used to express the CaEBP gene is deficient in several proteolytic enzymes which might be involved in the processing step to enter the vacuole, it is also conceivable that a signal sequence that may be used by EBP to enter the vacuole in C. albicans is not recognized by S. cerevisiae.
Finally, aminopeptidase I and other soluble vacuolar hydrolases show regulation during the growth cycle, exhibiting derepression under growth conditions when glucose or nitrogen is limited (Frey & Rohm, 1978) . EBP also shows regulation during the growth cycle, exhibiting peak levels of activity during rapid growth which diminishes as cells approach stationary phase. Interestingly, this regulation is only observed when the organism is grown in Sabouraud-dextrose medium as barely any oestrogen binding can be detected when the cells are grown in a yeast nitrogen base medium (YNB). This suggests that some factor in Sabouraud-dextrose medium that is not present in YNB is stimulatory for EBP production.
In conclusion, the data described in this report extend our studies on the C. albicans EBP and provide further evidence that the CaEBP gene that we have cloned encodes an EBP. The function of EBP remains unknown and whether it is involved in the pathogenicity of the organism is still unresolved. However, the finding that it is a vacuolar protein and the availability of a polyclonal antibody provide additional tools to investigate the role of EBP in C. albicans.
